Report cover image

Global Acetaminophen Injection Market Outlook and Growth Opportunities 2025

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 191 Pages
SKU # APRC20359429

Description

Summary

According to APO Research, the global Acetaminophen Injection market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.

The North American market for Acetaminophen Injection is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % from 2025 through 2031.

The Asia-Pacific market for Acetaminophen Injection is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

In China, the Acetaminophen Injection market is expected to rise from $ million to $ million by 2031, at a CAGR of I% from 2025 through 2031.

The Europe market for Acetaminophen Injection is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Major global companies in the Acetaminophen Injection market include Accord Healthcare, Eugia, Fresenius Kabi, Hikma, Mallinckrodt, Terumo, B. Braun Medical, Pfizer and Sandoz, etc. In 2024, the top three vendors accounted for approximately % of the market revenue.

This report presents an overview of global market for Acetaminophen Injection, revenue and gross margin. Analyses of the global market trends, with historic market revenue for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Acetaminophen Injection, also provides the value of main regions and countries. Of the upcoming market potential for Acetaminophen Injection, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Acetaminophen Injection revenue, market share and industry ranking of main companies, data from 2020 to 2025. Identification of the major stakeholders in the global Acetaminophen Injection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
All companies have demonstrated varying levels of sales growth and profitability over the past six years, while some companies have experienced consistent growth, others have shown fluctuations in performance. The overall trend suggests a positive outlook for the global Acetaminophen Injection company landscape, with companies adapting to market dynamics and maintaining profitability amidst changing conditions.
Acetaminophen Injection Segment by Company

Accord Healthcare
Eugia
Fresenius Kabi
Hikma
Mallinckrodt
Terumo
B. Braun Medical
Pfizer
Sandoz
Acetaminophen Injection Segment by Type

150mg/mL
10mg/mL
100mg/mL
Acetaminophen Injection Segment by Application

Hospital
Clinic
Acetaminophen Injection Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global Acetaminophen Injection status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Acetaminophen Injection key companies, revenue, market share, and recent developments.
3. To split the Acetaminophen Injection breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Acetaminophen Injection market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Acetaminophen Injection significant trends, drivers, influence factors in global and regions.
6. To analyze Acetaminophen Injection competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Acetaminophen Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Acetaminophen Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Acetaminophen Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Acetaminophen Injection industry.
Chapter 3: Detailed analysis of Acetaminophen Injection company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Acetaminophen Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Acetaminophen Injection in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.

Table of Contents

191 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Acetaminophen Injection Market Size, 2020 VS 2024 VS 2031
1.3 Global Acetaminophen Injection Market Size (2020-2031)
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Acetaminophen Injection Market Dynamics
2.1 Acetaminophen Injection Industry Trends
2.2 Acetaminophen Injection Industry Drivers
2.3 Acetaminophen Injection Industry Opportunities and Challenges
2.4 Acetaminophen Injection Industry Restraints
3 Acetaminophen Injection Market by Company
3.1 Global Acetaminophen Injection Company Revenue Ranking in 2024
3.2 Global Acetaminophen Injection Revenue by Company (2020-2025)
3.3 Global Acetaminophen Injection Company Ranking (2023-2025)
3.4 Global Acetaminophen Injection Company Manufacturing Base and Headquarters
3.5 Global Acetaminophen Injection Company Product Type and Application
3.6 Global Acetaminophen Injection Company Establishment Date
3.7 Market Competitive Analysis
3.7.1 Global Acetaminophen Injection Market Concentration Ratio (CR5 and HHI)
3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
3.7.3 2024 Acetaminophen Injection Tier 1, Tier 2, and Tier 3 Companies
3.8 Mergers and Acquisitions Expansion
4 Acetaminophen Injection Market by Type
4.1 Acetaminophen Injection Type Introduction
4.1.1 150mg/mL
4.1.2 10mg/mL
4.1.3 100mg/mL
4.2 Global Acetaminophen Injection Sales Value by Type
4.2.1 Global Acetaminophen Injection Sales Value by Type (2020 VS 2024 VS 2031)
4.2.2 Global Acetaminophen Injection Sales Value by Type (2020-2031)
4.2.3 Global Acetaminophen Injection Sales Value Share by Type (2020-2031)
5 Acetaminophen Injection Market by Application
5.1 Acetaminophen Injection Application Introduction
5.1.1 Hospital
5.1.2 Clinic
5.2 Global Acetaminophen Injection Sales Value by Application
5.2.1 Global Acetaminophen Injection Sales Value by Application (2020 VS 2024 VS 2031)
5.2.2 Global Acetaminophen Injection Sales Value by Application (2020-2031)
5.2.3 Global Acetaminophen Injection Sales Value Share by Application (2020-2031)
6 Acetaminophen Injection Regional Value Analysis
6.1 Global Acetaminophen Injection Sales Value by Region: 2020 VS 2024 VS 2031
6.2 Global Acetaminophen Injection Sales Value by Region (2020-2031)
6.2.1 Global Acetaminophen Injection Sales Value by Region: 2020-2025
6.2.2 Global Acetaminophen Injection Sales Value by Region (2026-2031)
6.3 North America
6.3.1 North America Acetaminophen Injection Sales Value (2020-2031)
6.3.2 North America Acetaminophen Injection Sales Value Share by Country, 2024 VS 2031
6.4 Europe
6.4.1 Europe Acetaminophen Injection Sales Value (2020-2031)
6.4.2 Europe Acetaminophen Injection Sales Value Share by Country, 2024 VS 2031
6.5 Asia-Pacific
6.5.1 Asia-Pacific Acetaminophen Injection Sales Value (2020-2031)
6.5.2 Asia-Pacific Acetaminophen Injection Sales Value Share by Country, 2024 VS 2031
6.6 South America
6.6.1 South America Acetaminophen Injection Sales Value (2020-2031)
6.6.2 South America Acetaminophen Injection Sales Value Share by Country, 2024 VS 2031
6.7 Middle East & Africa
6.7.1 Middle East & Africa Acetaminophen Injection Sales Value (2020-2031)
6.7.2 Middle East & Africa Acetaminophen Injection Sales Value Share by Country, 2024 VS 2031
7 Acetaminophen Injection Country-level Value Analysis
7.1 Global Acetaminophen Injection Sales Value by Country: 2020 VS 2024 VS 2031
7.2 Global Acetaminophen Injection Sales Value by Country (2020-2031)
7.2.1 Global Acetaminophen Injection Sales Value by Country (2020-2025)
7.2.2 Global Acetaminophen Injection Sales Value by Country (2026-2031)
7.3 USA
7.3.1 USA Acetaminophen Injection Sales Value Growth Rate (2020-2031)
7.3.2 USA Acetaminophen Injection Sales Value Share by Type, 2024 VS 2031
7.3.3 USA Acetaminophen Injection Sales Value Share by Application, 2024 VS 2031
7.4 Canada
7.4.1 Canada Acetaminophen Injection Sales Value Growth Rate (2020-2031)
7.4.2 Canada Acetaminophen Injection Sales Value Share by Type, 2024 VS 2031
7.4.3 Canada Acetaminophen Injection Sales Value Share by Application, 2024 VS 2031
7.5 Mexico
7.5.1 Mexico Acetaminophen Injection Sales Value Growth Rate (2020-2031)
7.5.2 Mexico Acetaminophen Injection Sales Value Share by Type, 2024 VS 2031
7.5.3 Mexico Acetaminophen Injection Sales Value Share by Application, 2024 VS 2031
7.6 Germany
7.6.1 Germany Acetaminophen Injection Sales Value Growth Rate (2020-2031)
7.6.2 Germany Acetaminophen Injection Sales Value Share by Type, 2024 VS 2031
7.6.3 Germany Acetaminophen Injection Sales Value Share by Application, 2024 VS 2031
7.7 France
7.7.1 France Acetaminophen Injection Sales Value Growth Rate (2020-2031)
7.7.2 France Acetaminophen Injection Sales Value Share by Type, 2024 VS 2031
7.7.3 France Acetaminophen Injection Sales Value Share by Application, 2024 VS 2031
7.8 U.K.
7.8.1 U.K. Acetaminophen Injection Sales Value Growth Rate (2020-2031)
7.8.2 U.K. Acetaminophen Injection Sales Value Share by Type, 2024 VS 2031
7.8.3 U.K. Acetaminophen Injection Sales Value Share by Application, 2024 VS 2031
7.9 Italy
7.9.1 Italy Acetaminophen Injection Sales Value Growth Rate (2020-2031)
7.9.2 Italy Acetaminophen Injection Sales Value Share by Type, 2024 VS 2031
7.9.3 Italy Acetaminophen Injection Sales Value Share by Application, 2024 VS 2031
7.10 Spain
7.10.1 Spain Acetaminophen Injection Sales Value Growth Rate (2020-2031)
7.10.2 Spain Acetaminophen Injection Sales Value Share by Type, 2024 VS 2031
7.10.3 Spain Acetaminophen Injection Sales Value Share by Application, 2024 VS 2031
7.11 Russia
7.11.1 Russia Acetaminophen Injection Sales Value Growth Rate (2020-2031)
7.11.2 Russia Acetaminophen Injection Sales Value Share by Type, 2024 VS 2031
7.11.3 Russia Acetaminophen Injection Sales Value Share by Application, 2024 VS 2031
7.12 Netherlands
7.12.1 Netherlands Acetaminophen Injection Sales Value Growth Rate (2020-2031)
7.12.2 Netherlands Acetaminophen Injection Sales Value Share by Type, 2024 VS 2031
7.12.3 Netherlands Acetaminophen Injection Sales Value Share by Application, 2024 VS 2031
7.13 Nordic Countries
7.13.1 Nordic Countries Acetaminophen Injection Sales Value Growth Rate (2020-2031)
7.13.2 Nordic Countries Acetaminophen Injection Sales Value Share by Type, 2024 VS 2031
7.13.3 Nordic Countries Acetaminophen Injection Sales Value Share by Application, 2024 VS 2031
7.14 China
7.14.1 China Acetaminophen Injection Sales Value Growth Rate (2020-2031)
7.14.2 China Acetaminophen Injection Sales Value Share by Type, 2024 VS 2031
7.14.3 China Acetaminophen Injection Sales Value Share by Application, 2024 VS 2031
7.15 Japan
7.15.1 Japan Acetaminophen Injection Sales Value Growth Rate (2020-2031)
7.15.2 Japan Acetaminophen Injection Sales Value Share by Type, 2024 VS 2031
7.15.3 Japan Acetaminophen Injection Sales Value Share by Application, 2024 VS 2031
7.16 South Korea
7.16.1 South Korea Acetaminophen Injection Sales Value Growth Rate (2020-2031)
7.16.2 South Korea Acetaminophen Injection Sales Value Share by Type, 2024 VS 2031
7.16.3 South Korea Acetaminophen Injection Sales Value Share by Application, 2024 VS 2031
7.17 India
7.17.1 India Acetaminophen Injection Sales Value Growth Rate (2020-2031)
7.17.2 India Acetaminophen Injection Sales Value Share by Type, 2024 VS 2031
7.17.3 India Acetaminophen Injection Sales Value Share by Application, 2024 VS 2031
7.18 Australia
7.18.1 Australia Acetaminophen Injection Sales Value Growth Rate (2020-2031)
7.18.2 Australia Acetaminophen Injection Sales Value Share by Type, 2024 VS 2031
7.18.3 Australia Acetaminophen Injection Sales Value Share by Application, 2024 VS 2031
7.19 Southeast Asia
7.19.1 Southeast Asia Acetaminophen Injection Sales Value Growth Rate (2020-2031)
7.19.2 Southeast Asia Acetaminophen Injection Sales Value Share by Type, 2024 VS 2031
7.19.3 Southeast Asia Acetaminophen Injection Sales Value Share by Application, 2024 VS 2031
7.20 Brazil
7.20.1 Brazil Acetaminophen Injection Sales Value Growth Rate (2020-2031)
7.20.2 Brazil Acetaminophen Injection Sales Value Share by Type, 2024 VS 2031
7.20.3 Brazil Acetaminophen Injection Sales Value Share by Application, 2024 VS 2031
7.21 Argentina
7.21.1 Argentina Acetaminophen Injection Sales Value Growth Rate (2020-2031)
7.21.2 Argentina Acetaminophen Injection Sales Value Share by Type, 2024 VS 2031
7.21.3 Argentina Acetaminophen Injection Sales Value Share by Application, 2024 VS 2031
7.22 Chile
7.22.1 Chile Acetaminophen Injection Sales Value Growth Rate (2020-2031)
7.22.2 Chile Acetaminophen Injection Sales Value Share by Type, 2024 VS 2031
7.22.3 Chile Acetaminophen Injection Sales Value Share by Application, 2024 VS 2031
7.23 Colombia
7.23.1 Colombia Acetaminophen Injection Sales Value Growth Rate (2020-2031)
7.23.2 Colombia Acetaminophen Injection Sales Value Share by Type, 2024 VS 2031
7.23.3 Colombia Acetaminophen Injection Sales Value Share by Application, 2024 VS 2031
7.24 Peru
7.24.1 Peru Acetaminophen Injection Sales Value Growth Rate (2020-2031)
7.24.2 Peru Acetaminophen Injection Sales Value Share by Type, 2024 VS 2031
7.24.3 Peru Acetaminophen Injection Sales Value Share by Application, 2024 VS 2031
7.25 Saudi Arabia
7.25.1 Saudi Arabia Acetaminophen Injection Sales Value Growth Rate (2020-2031)
7.25.2 Saudi Arabia Acetaminophen Injection Sales Value Share by Type, 2024 VS 2031
7.25.3 Saudi Arabia Acetaminophen Injection Sales Value Share by Application, 2024 VS 2031
7.26 Israel
7.26.1 Israel Acetaminophen Injection Sales Value Growth Rate (2020-2031)
7.26.2 Israel Acetaminophen Injection Sales Value Share by Type, 2024 VS 2031
7.26.3 Israel Acetaminophen Injection Sales Value Share by Application, 2024 VS 2031
7.27 UAE
7.27.1 UAE Acetaminophen Injection Sales Value Growth Rate (2020-2031)
7.27.2 UAE Acetaminophen Injection Sales Value Share by Type, 2024 VS 2031
7.27.3 UAE Acetaminophen Injection Sales Value Share by Application, 2024 VS 2031
7.28 Turkey
7.28.1 Turkey Acetaminophen Injection Sales Value Growth Rate (2020-2031)
7.28.2 Turkey Acetaminophen Injection Sales Value Share by Type, 2024 VS 2031
7.28.3 Turkey Acetaminophen Injection Sales Value Share by Application, 2024 VS 2031
7.29 Iran
7.29.1 Iran Acetaminophen Injection Sales Value Growth Rate (2020-2031)
7.29.2 Iran Acetaminophen Injection Sales Value Share by Type, 2024 VS 2031
7.29.3 Iran Acetaminophen Injection Sales Value Share by Application, 2024 VS 2031
7.30 Egypt
7.30.1 Egypt Acetaminophen Injection Sales Value Growth Rate (2020-2031)
7.30.2 Egypt Acetaminophen Injection Sales Value Share by Type, 2024 VS 2031
7.30.3 Egypt Acetaminophen Injection Sales Value Share by Application, 2024 VS 2031
8 Company Profiles
8.1 Accord Healthcare
8.1.1 Accord Healthcare Comapny Information
8.1.2 Accord Healthcare Business Overview
8.1.3 Accord Healthcare Acetaminophen Injection Revenue and Gross Margin (2020-2025)
8.1.4 Accord Healthcare Acetaminophen Injection Product Portfolio
8.1.5 Accord Healthcare Recent Developments
8.2 Eugia
8.2.1 Eugia Comapny Information
8.2.2 Eugia Business Overview
8.2.3 Eugia Acetaminophen Injection Revenue and Gross Margin (2020-2025)
8.2.4 Eugia Acetaminophen Injection Product Portfolio
8.2.5 Eugia Recent Developments
8.3 Fresenius Kabi
8.3.1 Fresenius Kabi Comapny Information
8.3.2 Fresenius Kabi Business Overview
8.3.3 Fresenius Kabi Acetaminophen Injection Revenue and Gross Margin (2020-2025)
8.3.4 Fresenius Kabi Acetaminophen Injection Product Portfolio
8.3.5 Fresenius Kabi Recent Developments
8.4 Hikma
8.4.1 Hikma Comapny Information
8.4.2 Hikma Business Overview
8.4.3 Hikma Acetaminophen Injection Revenue and Gross Margin (2020-2025)
8.4.4 Hikma Acetaminophen Injection Product Portfolio
8.4.5 Hikma Recent Developments
8.5 Mallinckrodt
8.5.1 Mallinckrodt Comapny Information
8.5.2 Mallinckrodt Business Overview
8.5.3 Mallinckrodt Acetaminophen Injection Revenue and Gross Margin (2020-2025)
8.5.4 Mallinckrodt Acetaminophen Injection Product Portfolio
8.5.5 Mallinckrodt Recent Developments
8.6 Terumo
8.6.1 Terumo Comapny Information
8.6.2 Terumo Business Overview
8.6.3 Terumo Acetaminophen Injection Revenue and Gross Margin (2020-2025)
8.6.4 Terumo Acetaminophen Injection Product Portfolio
8.6.5 Terumo Recent Developments
8.7 B. Braun Medical
8.7.1 B. Braun Medical Comapny Information
8.7.2 B. Braun Medical Business Overview
8.7.3 B. Braun Medical Acetaminophen Injection Revenue and Gross Margin (2020-2025)
8.7.4 B. Braun Medical Acetaminophen Injection Product Portfolio
8.7.5 B. Braun Medical Recent Developments
8.8 Pfizer
8.8.1 Pfizer Comapny Information
8.8.2 Pfizer Business Overview
8.8.3 Pfizer Acetaminophen Injection Revenue and Gross Margin (2020-2025)
8.8.4 Pfizer Acetaminophen Injection Product Portfolio
8.8.5 Pfizer Recent Developments
8.9 Sandoz
8.9.1 Sandoz Comapny Information
8.9.2 Sandoz Business Overview
8.9.3 Sandoz Acetaminophen Injection Revenue and Gross Margin (2020-2025)
8.9.4 Sandoz Acetaminophen Injection Product Portfolio
8.9.5 Sandoz Recent Developments
9 Concluding Insights
10 Appendix
10.1 Reasons for Doing This Study
10.2 Research Methodology
10.3 Research Process
10.4 Authors List of This Report
10.5 Data Source
10.5.1 Secondary Sources
10.5.2 Primary Sources
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.